Integrated computational analysis identifies therapeutic targets with dual action in cancer cells and T cells
Ce Luo(Peking University), Zexian Zeng(Peking University), Wubing Zhang(California Institute for Regenerative Medicine), Yiteng Jin(Peking University), Qiang Pan‐Hammarström(Karolinska Institutet), Zhidong Gao(Peking University), Luhua Lai(Peking University), Chenfei Wang(Tongji University), Sitong Ye(Yale University), Zongxu Zhang(Peking University), Rui Zhang(Center for Life Sciences), Xiaohong Li(Central South University), Dian Li(Fudan University), Rui Guo(Sun Yat-sen University), Peng Zhang(Nanjing Tech University), Teng Xue(Nanjing Medical University), Lijian Wu(Tsinghua University), Yanping Zhao(Fujian Medical University), Dengyu Pan(Yunnan Agricultural University), Yufeng He(Center for Life Sciences), Kai W. Wucherpfennig(Dana-Farber Cancer Institute)
Cited by 31
Related Papers
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
|Cell|2018|1.5k
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
|Nature Medicine|2018|927
Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma
|Cancer Cell|2021|607
Genomic basis for RNA alterations in cancer
|Nature|2020|424